U.S. RESEARCH ROUNDUP-Ncino, Newmont, Seagen

Clean Energy Fuels

14/03/2023 07:30

March 14 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Ncino, Newmont and Seagen, on Tuesday. 
    
    HIGHLIGHTS
                 * Crestwood Equity Partners LP  CEQP.N : JP Morgan cuts to neutral from overweight
 
                 * MPLX LP  MPLX.N : JP Morgan raises to overweight from neutral    
 
                 * Ncino Inc  NCNO.O : Piper Sandler cuts to neutral from overweight     
 
                 * Newmont  NEM.N : Canaccord Genuity raises to buy from hold 
 
                 * Seagen Inc  SGEN.O : Needham cuts to hold from buy         
 
        
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order. 
    
                 * Acadia Pharmaceuticals Inc  ACAD.O : Canaccord Genuity raises target price to $26 from $24 
 
                 * Acadia Pharmaceuticals Inc  ACAD.O : Mizuho raises target price to $20 from $19 
 
                 * Acadia Pharmaceuticals Inc  ACAD.O : TD Cowen raises target price to $28 from $24 
 
                 * Charles Schwab Corp  SCHW.N : Piper Sandler cuts target price to $95 from $100 
 
                 * Chesapeake Utilities Corp  CPK.N : RBC raises target price to $133 from $131 
 
                 * Clean Energy Fuels Corp  CLNE.O : Jefferies cuts target price to $7 from $9 
 
                 * Crestwood Equity Partners LP  CEQP.N : JP Morgan cuts to neutral from overweight
 
                 * Crestwood Equity Partners LP  CEQP.N : JP Morgan cuts target price to $28 from $31 
 
                 * Durect Corp  DRRX.O : Jonesresearch starts with buy rating and $37 price target 
 
                 * Eagle Pharmaceuticals Inc  EGRX.O : Piper Sandler cuts target price to $31 from $41 
 
                 * Edgio Inc  EGIO.O : D.A. Davidson cuts target price to $1 from $1.25 
 
                 * First Guaranty Bancshares Inc  FGBI.O : D.A. Davidson cuts target price by $8.25 to $18.25 
 
                 * Gitlab Inc  GTLB.O : Piper Sandler cuts target price to $50 from $58 
 
                 * Gitlab Inc  GTLB.O : RBC cuts target price to $45 from $60 
 
                 * Huntington Bancshares Inc  HBAN.O : RBC cuts target price to $16 from $18 
 
                 * Limoneira Co  LMNR.O : Stephens raises target price to $20 from $19 
 
                 * Methode Electronics Inc  MEI.N : Baird cuts target price to $49 from $52 
 
                 * Momentive Global Inc  MNTV.O : Credit Suisse cuts target price to $9.46 from $13 
 
                 * MPLX LP  MPLX.N : JP Morgan raises to overweight from neutral
 
                 * MPLX LP  MPLX.N : JP Morgan raises target price to $41 from $37 
 
                 * Ncino Inc  NCNO.O : Piper Sandler cuts target price to $22 from $30 
 
                 * Ncino Inc  NCNO.O : Piper Sandler cuts to neutral from overweight 
 
                 * Newmont  NEM.N : Canaccord Genuity raises target price to $55 from $53 
 
                 * Newmont  NEM.N : Canaccord Genuity raises to buy from hold 
 
                 * One Liberty Properties Inc  OLP.N : Colliers Securities cuts target price by $1 to $24 
 
                 * Ovintiv Inc  OVV.N : Credit Suisse cuts target price to $60 from $70 
 
                 * Pinnacle West Capital Corp  PNW.N : Credit Suisse raises to outperform from neutral
 
                 * Pinnacle West Capital Corp  PNW.N : Credit Suisse raises target price to $80 from $77 
 
                 * Provention Bio Inc  PRVB.O : Jefferies cuts to hold from buy
 
                 * Provention Bio Inc  PRVB.O : Jefferies raises target price to $25 from $22 
 
                 * Q2 Holdings Inc  QTWO.N : Piper Sandler cuts target price to $20 from $26 
 
                 * Qualtrics International Inc  XM.O : Piper Sandler cuts to neutral from overweight 
 
                 * Science 37 Holdings Inc  SNCE.O : TD Cowen cuts target price to $2.50 from $3 
 
                 * Seagen Inc  SGEN.O : Needham cuts to hold from buy 
 
                 * Seagen Inc  SGEN.O : Raymond James cuts to market perform from strong buy 
 
                 * Seagen Inc  SGEN.O : RBC raises target price to $229 from $155 
 
                 * T2 Biosystems Inc  TTOO.O : Canaccord Genuity cuts target price to $0.50 from $1.50 
 
                 * Trevi Therapeutics Inc  TRVI.O : Jonesresearch starts with buy rating and $7 price target 
 
                 * Truist Financial Corp  TFC.N : Baird raises to outperform rating 
 
                 * Whole Earth Brands Inc  FREE.O : Canaccord Genuity cuts target price to $6 from $8 
 
                 * Wintrust Financial Corp  WTFC.O : RBC cuts target price to $95 from $108 
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))